Search Results - Xiao-Xu Wang

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study

    Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study by Ji-Xin Tian, Ping Zhang, Xiao-Xu Wang, Jin-Wen Li, Dong-Xue Liu, Yi-Ying Liu, Zhi-Jian Xiao, Wen-Juan Miao

    Published 2025-07-01

    BackgroundVenetoclax (VEN), an orally bioavailable B-cell lymphoma-2 inhibitor, shows promising activity in patients with myelodysplastic syndromes (MDS) when combined with hypomethylating agents (HMAs). However, research regarding the VEN exposure in Chinese patients with MDS remains notably sparse...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Mediation effects of age, intramuscular adipose tissue index and serum albumin on survival status in initial dialysis patients

    Mediation effects of age, intramuscular adipose tissue index and serum albumin on survival status in initial dialysis patients by Meng-huan Wu, Yu-ting Gao, Yu-xin Ren, Wen Zhou, Jing Zheng, Shi-mei Hou, Yao Wang, Jing-yuan Cao, Xiao-xu Wang, Yan Yang, Bin Wang, Min Yang, Jing-ting Jiang, Min Li

    Published 2025-12-01

    Background To explore the associations of age, intramuscular adipose tissue index (IATI), and serum albumin with survival status in initial dialysis patients and the mediating effects.Methods Totally 1,044 Chinese initial dialysis patients from four hospitals (2014-2020) were eventually enrolled and...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: